News and Information

Investor

Zhejiang Ausun Pharmaceutical Co., Ltd. Special Raw Material and Key Pharmaceutical Intermediate Production Base Construction Project (Preliminary) Completion Environmental Protection Acceptance Monitoring Report (Revised Edition)


Release Date:

2023-12-15

Zhejiang Ausun  Pharmaceutical Co., Ltd. Special Raw Material and Key Pharmaceutical Intermediate Production Base Construction Project (Preliminary) Completion Environmental Protection Acceptance Monitoring Report (Revised Edition)

Related News

Leading the Peptide Pipeline: Aoxiang Pharmaceutical Deeply Engages in Discussions on Reaction Safety Risk Assessment, Jointly Mapping Out the Industry’s Blueprint

In recent years, Aoxiang Pharmaceutical has, while maintaining its core strengths in active pharmaceutical ingredients, steadfastly implemented a “transformation and upgrading” strategy, prioritizing the research and development of peptide drugs, oligonucleotides, and synthetic biology technologies.

2026-01-13